EID Parry (India) Ltd (EIDPARRY)

Fast Moving Consumer Goods · Sugar · NSE · Updated 1 September 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹805.35 ↓ 28.48% (1Y)

🎯 Key Takeaways

EID Parry India is in a strategic transition phase, shifting focus from a loss-making sugar refinery to higher-margin nutraceutical and consumer segments while managing debt and operational restructuring. Management is prioritizing balance sheet strengthening and long-term profitability over short-term sugar segment gains, signaling a deliberate pivot toward sustainable growth in core businesses.
Revenue grew 14.4% QoQ to ₹9,018 in Q1FY27.
⚠️ The company continues to face near-term losses from the closure of PSRIPL, including impairment charges and termination costs, which could pressure pr

Market Cap

₹14,332

P/E Ratio

30.8

P/B Ratio

1.63

ROE

13.9%

ROCE

20.4%

Debt/Equity

0.32

Div Yield

0.25%

Promoter

41.3%

✨ Ask AI About EIDPARRY 📊 Interactive Charts

📖 The Story

EID Parry India is in a strategic transition phase, shifting focus from a loss-making sugar refinery to higher-margin nutraceutical and consumer segments while managing debt and operational restructuring. Management is prioritizing balance sheet strengthening and long-term profitability over short-term sugar segment gains, signaling a deliberate pivot toward sustainable growth in core businesses.

📰 What's Happening

In Q1 FY27, sugar segment revenue rose to ₹410 crores from ₹347 crores YoY, driven by volume growth despite pricing pressure, as highlighted in the August 19, 2026 filing. Management has set a target of 12-15% EBITDA margins for the Nutra segment contingent on scale expansion and has initiated asset sales to recover value, including the closure of Parry Sugars Refinery India Private Limited (PSRIPL) effective March 31, 2026, which incurred a ₹1868 lakh impairment charge. The board approved the closure and associated costs during its August 12, 2026 meeting, finalizing a strategic exit from non-core operations. Nutra is expected to achieve its highest-ever revenue this fiscal year, with breakeven in consumer goods targeted within 4-5 quarters. Debt reduction and balance sheet strengthening are explicitly prioritized by FY27, supported by operational efficiency measures and recovery of unrecovered UAE receivables.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	8,724	11,624	10,312	7,882	9,018
Operating Profit	630	1,040	632	386	508
OPM %	7.2%	8.9%	6.1%	4.9%	5.6%
Net Profit	464	766	437	-287	312
EPS	₹13.85	₹23.87	₹13.05	₹-18.74	₹7.96

Revenue shows volatility but stabilization, with Q1 FY27 revenue at ₹9,018 crores reflecting consolidation of PSRIPL operations prior to closure, though this was down from ₹11,624 crores in September 2025. Operating performance improved sequentially, with Q1 FY27 operating profit of ₹508 crores and margin of 5.6%, up from ₹386 crores and 4.9% in Q4 FY26, despite a net loss of ₹312 crores due to one-time charges. The company posted a consolidated loss of ₹2058 lakhs in Q1 FY27, primarily due to the PSRIPL impairment and investment write-downs, but standalone operations narrowed losses to ₹89 crores. This suggests that while core segments are stabilizing, transitional costs are weighing on profitability in the near term. The focus remains on improving Nutra margins and achieving breakeven in consumer goods within 4-5 quarters, which could drive future profitability.

🔮 Management Outlook & What's Next

Management has provided forward-looking guidance on margin improvement and breakeven timelines, stating that Nutra aims to achieve 12-15% EBITDA margins contingent on scale and targeting its highest-ever revenue this fiscal year, with consumer goods breakeven expected within 4-5 quarters. Debt reduction and balance sheet strengthening are explicitly outlined as priorities by FY27, supported by operational efficiency initiatives and asset sales. However, no specific debt reduction targets or timelines were disclosed in the filings, and management did not provide detailed financial targets beyond margin and breakeven milestones. The focus remains on structural profitability improvements rather than immediate earnings growth.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

Item	Mar 2025	Mar 2025	Mar 2026	Mar 2026
Equity Capital	18	18	18	18
Reserves	7,406	7,918	8,628	8,797
Borrowings	1,714	2,704	2,666	2,854
Total Liabilities	21,959	24,381	29,958	29,254
Fixed Assets	5,090	5,144	5,709	8,224
Investments	1,329	1,453	3,750	2,545
Total Assets	21,959	24,381	29,958	29,254

The balance sheet shows a stable equity base of ₹18 crores with growing reserves, indicating retained earnings and capital reserves are expanding, while borrowings have declined slightly from ₹2,704 crores in March 2025 to ₹2,666 crores in March 2026, reflecting early progress in debt reduction. Total assets remain stable around ₹29,000 crores, suggesting no aggressive capital deployment, consistent with management's focus on consolidation and deleveraging. The closure of PSRIPL and associated asset sales are likely contributing to improved asset quality and potential off-balance sheet cleanup, supporting a strategic shift toward a leaner, more focused business model.

💰 Cash Flow Statement (₹ Cr)

Item	Mar 2026
Operating	+1,542
Investing	-174
Financing	-551
Net Cash Flow	+817

👥 Shareholding Pattern

Category	Q2FY26	Q3FY26	Q4FY26	Q1FY27
Promoters	41.5%	41.4%	41.4%	41.3%
FII	12.8%	12.6%	12.2%	11.2%
DII	15.6%	16.3%	16.8%	16.7%
Public	23.3%	22.7%	22.8%	24.0%
# Shareholders	1,19,631	1,13,020	1,12,286	1,24,851

Institutional investor interest is rising, with FII holdings increasing from 12.21% in Q4 FY26 to 11.21% in Q1 FY27 (though slightly down from 12.77% in Q2 FY26), while DII holdings remained relatively stable around 16%. Promoter holding remains steady near 41.28%, indicating no dilution or stake sale. The number of shareholders has grown to 1,24,851 in Q1 FY27 from 1,12,286 in Q4 FY26, suggesting increasing retail participation and potential market interest. This broadening shareholder base may reflect growing confidence in the company’s restructuring narrative and long-term turnaround potential.

⚖️ Peer Comparison — Sugar

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
EIDPARRY	14,332	30.8	20.4%	13.9%	0.32
BALRAMCHIN	13,837	35.7	9.7%	9.8%	0.69
TRIVENI	6,258	22.8	8.4%	8.7%	0.63
BAJAJHIND	5,183	15.9	1.4%	12.2%	3.74
RENUKA	5,125	—	-2.9%	46.6%	-3.50
BANARISUG	4,984	40.9	7.3%	6.8%	0.08
DALMIASUG	3,866	19.0	7.0%	6.3%	0.55
AVADHSUGAR	1,663	25.2	6.8%	5.9%	1.25
GODAVARIB	1,230	8011.7	3.8%	0.0%	0.63
UTTAMSUGAR	1,142	13.1	10.0%	11.1%	1.06

🔗 Peer Stock Analyses

BALRAMCHIN TRIVENI BAJAJHIND RENUKA BANARISUG

⚠️ Risk Factors

1. The company continues to face near-term losses from the closure of PSRIPL, including impairment charges and termination costs, which could pressure profitability despite revenue growth. 2. Nutra segment margins are targeted at 12-15% contingent on scale, but no guarantees are provided, and current operating losses in consumer products suggest scale-up may take longer than anticipated. 3. Sugar segment performance remains vulnerable to volatile global prices and demand, with management noting protection only through recovery rates, not pricing power. 4. Unrecovered UAE receivables of ₹4,572 lakhs pose a foreign exchange and credit risk that may impact cash flows if not resolved.

📋 Recent Filings

🧠 Analyst's Read

EID Parry India is executing a deliberate strategic shift from a loss-making sugar refinery to higher-margin nutraceutical and consumer businesses, with management targeting margin improvement and breakeven within 4-5 quarters. Investors should monitor progress toward Nutra margin targets, debt reduction pace, and resolution of UAE receivables as key near-term catalysts. The company is in a transitional phase with improving operational stability but ongoing transitional costs, making execution risk a critical factor in the coming quarters.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on EIDPARRY

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EIDPARRY files new disclosures

Track EIDPARRY filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EIDPARRY — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd